for the Period Ended 30 April 2025
| Profit and loss | |
| Balance sheet | |
| Additional notes | |
| Community Interest Report |
for the Period Ended
| 13 months to 30 April 2025 | ||
|---|---|---|
|
|
£ |
|
| Turnover: |
|
|
| Cost of sales: |
(
|
|
| Gross profit(or loss): |
|
|
| Administrative expenses: |
(
|
|
| Operating profit(or loss): |
|
|
| Profit(or loss) before tax: |
|
|
| Profit(or loss) for the financial year: |
|
As at
| Notes | 13 months to 30 April 2025 | ||
|---|---|---|---|
|
|
£ |
||
| Current assets | |||
| Cash at bank and in hand: |
|
||
| Total current assets: |
|
||
| Net current assets (liabilities): |
|
||
| Total assets less current liabilities: |
|
||
| Total net assets (liabilities): |
|
||
| Members' funds | |||
| Profit and loss account: |
|
||
| Total members' funds: |
|
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 30 April 2025
Basis of measurement and preparation
for the Period Ended 30 April 2025
| 13 months to 30 April 2025 | ||
|---|---|---|
| Average number of employees during the period |
|
During the financial year, the company did not undertake any operational activities or community projects and therefore did not deliver any direct community benefit. The company was established with the intention of pursuing community benefit objectives; however, due to changes in the directors' personal circumstances, including one director relocating overseas and another undergoing significant medical treatment, the company did not commence its planned activities during the period.
No consultation with stakeholders
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
9 March 2026
And signed on behalf of the board by:
Name: Chloe Houlden
Status: Director